130 related articles for article (PubMed ID: 22507656)
1. Algorithm to assess causality after individual adverse events following immunizations.
Halsey NA; Edwards KM; Dekker CL; Klein NP; Baxter R; Larussa P; Marchant C; Slade B; Vellozzi C;
Vaccine; 2012 Aug; 30(39):5791-8. PubMed ID: 22507656
[TBL] [Abstract][Full Text] [Related]
2. Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use.
Tozzi AE; Asturias EJ; Balakrishnan MR; Halsey NA; Law B; Zuber PL
Vaccine; 2013 Oct; 31(44):5041-6. PubMed ID: 24021304
[TBL] [Abstract][Full Text] [Related]
3. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
[TBL] [Abstract][Full Text] [Related]
4. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
Loughlin AM; Marchant CD; Adams W; Barnett E; Baxter R; Black S; Casey C; Dekker C; Edwards KM; Klein J; Klein NP; LaRussa P; Sparks R; Jakob K
Vaccine; 2012 Nov; 30(50):7253-9. PubMed ID: 23063829
[TBL] [Abstract][Full Text] [Related]
5. Adverse events following immunization: is this time for the use of WHO causality assessment?
Tafuri S; Gallone MS; Calabrese G; Germinario C
Expert Rev Vaccines; 2015 May; 14(5):625-7. PubMed ID: 25805053
[TBL] [Abstract][Full Text] [Related]
6. Application of the revised WHO causality assessment protocol for adverse events following immunization in India.
Singh AK; Wagner AL; Joshi J; Carlson BF; Aneja S; Boulton ML
Vaccine; 2017 Jul; 35(33):4197-4202. PubMed ID: 28648545
[TBL] [Abstract][Full Text] [Related]
7. Strengthening of causality assessment of adverse events following immunization in the WHO South East Asia and Western Pacific regions: Lessons from the 2014 SEAR inter-country workshop.
MacDonald NE; Guichard S; Amarasinghe A; Balakrishnan MR;
Vaccine; 2015 Nov; 33(48):6902-7. PubMed ID: 25617790
[TBL] [Abstract][Full Text] [Related]
8. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
[TBL] [Abstract][Full Text] [Related]
9. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001.
Schumacher Z; Bourquin C; Heininger U
Vaccine; 2010 May; 28(24):4059-64. PubMed ID: 20406662
[TBL] [Abstract][Full Text] [Related]
11. Causality Assessment Guidelines for Adverse Events Following Immunization with a Focus on Guillain-Barré Syndrome.
Lee H; Kang HY; Cho S; Park S; Kim AY; Jung SY; Seong BL; Lee YM
Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32102455
[TBL] [Abstract][Full Text] [Related]
12. Lessons on causality assessment and communications from the 2019 South-East Asia Regional (SEAR) workshop on inter-country expert review of selected Adverse Events Following Immunization (AEFI) cases.
MacDonald NE; Guichard S; Arora N; Menning L; Wilhelm E;
Vaccine; 2020 Jul; 38(32):4924-4932. PubMed ID: 31611095
[TBL] [Abstract][Full Text] [Related]
13. Causality assessment of adverse events following immunization: the problem of multifactorial pathology.
Bellavite P
F1000Res; 2020; 9():170. PubMed ID: 32269767
[TBL] [Abstract][Full Text] [Related]
14. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.
Ouandaogo CR; Yaméogo TM; Diomandé FV; Sawadogo C; Ouédraogo B; Ouédraogo-Traoré R; Pezzoli L; Djingarey MH; Mbakuliyemo N; Zuber PL
Vaccine; 2012 May; 30 Suppl 2():B46-51. PubMed ID: 22230584
[TBL] [Abstract][Full Text] [Related]
15. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
[TBL] [Abstract][Full Text] [Related]
16. [Literature review of adverse events following immunization of Bacillus Calemtte-Guerin vaccine].
Wu WD; Liu DW; Li L
Zhongguo Yi Miao He Mian Yi; 2009 Dec; 15(6):491-5. PubMed ID: 20518321
[TBL] [Abstract][Full Text] [Related]
17. Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.
Williams SE; Klein NP; Halsey N; Dekker CL; Baxter RP; Marchant CD; LaRussa PS; Sparks RC; Tokars JI; Pahud BA; Aukes L; Jakob K; Coronel S; Choi H; Slade BA; Edwards KM
Vaccine; 2011 Sep; 29(40):6920-7. PubMed ID: 21801776
[TBL] [Abstract][Full Text] [Related]
18. Active surveillance for adverse events following immunization.
Crawford NW; Clothier H; Hodgson K; Selvaraj G; Easton ML; Buttery JP
Expert Rev Vaccines; 2014 Feb; 13(2):265-76. PubMed ID: 24350637
[TBL] [Abstract][Full Text] [Related]
19. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.
Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B;
Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria.
Clothier HJ; Crawford NW; Kempe A; Buttery JP
Commun Dis Intell Q Rep; 2011 Dec; 35(4):294-8. PubMed ID: 22624490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
